Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015

Author:

MacNeil Jessica R.,Rubin Lorry,Folaranmi Temitope,Ortega-Sanchez Ismael R.,Patel Manisha,Martin Stacey W.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference20 articles.

1. Accelerated approval of new drugs for serious or life-threatening illnesses, 21 C.F.R. Sect. 314.500 (2015). Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=314&showFR=1&subpartNode=21:5.0.1.1.4.8.

2. Bhuyan P, Eiden J, Jones TR, Immunogenicity of human papilloma vaccine coadministered with an investigational bivalent rLP2086 vaccine against meningococcal serogroup B in healthy adolescents. Philadelphia, PA: IDWeek; 2014. Available at http://ofid.oxfordjournals.org/content/1/suppl_1/S317.2.full?sid=25a2b12f-c211-4ecc-bb47-e6ceba7bb4a2.

3. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.;Richmond;Lancet Infect Dis,2012

4. Vesikari T, Ostergaard L, Diez-Domingo J, Meningococcal serogroup B bivalent rLP2086 vaccine elicits broad and robust serum bactericidal responses in healthy adolescents. J Pediatric Infect Dis Soc; 2015. Available at http://jpids.oxfordjournals.org/content/early/2015/08/03/jpids.piv039.full.

5. Vesikari T, Wysocki J, Kieninger D, Immunogenicity, safety, and tolerability of bivalent rLP2086 meningococcal group B vaccine administered concomitantly with diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine to healthy adolescents. In: Proceedings of the 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases; May 6–16, 2014, Dublin, Ireland.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3